Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    OnKure Therapeutics Inc.

    NASDAQ: OKUR · Real-Time Price · USD
    2.53
    -0.14 (-5.24%)
    At close: Aug 15, 2025, 3:59 PM
    2.44
    -3.63%
    After-hours: Aug 15, 2025, 07:38 PM EDT

    OnKure Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 212K 212K 419K 12K 12K 151K 291K 43K n/a n/a
    Gross Profit
    		 -212K -212K -419K -12K -12K -151K -291K -43K n/a n/a
    Operating Income
    		 -16.32M -17M -33.8M -4.66M -14.34M -9.83M 21.11M -20.89M -8.63M -8.75M
    Interest Income
    		 934K 1.07M n/a n/a 230K 295K n/a n/a 451K 73K
    Pretax Income
    		 -15.39M -15.93M -35.19M -3.69M -14.14M -9.54M 18.52M -19.2M -8.18M -8.68M
    Net Income
    		 -15.39M -15.93M -35.19M -3.69M -14.14M -9.54M 18.52M -19.2M -8.18M -8.68M
    Selling & General & Admin
    		 3.62M 3.99M -3.56M 3.76M 3.59M 1.26M -14.22M 7.27M 1.12M 1.23M
    Research & Development
    		 12.5M 13.01M 37.36M 904K 10.75M 8.57M -6.89M 13.62M 7.51M 7.52M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 16.11M 17M 33.8M 4.66M 14.34M 9.83M -21.11M 20.89M 8.63M 8.75M
    Interest Expense
    		 n/a n/a n/a n/a 26K n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 16.32M 17M 33.8M 4.66M 14.34M 9.83M -21.11M 20.89M 8.63M 8.75M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 13.51M 13.42M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M
    Shares Outstanding (Diluted)
    		 13.51M 13.42M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M 13.34M
    EPS (Basic)
    		 -1.14 -1.19 -2.64 -0.28 -1.06 -0.71 1.39 -1.44 -0.61 -0.65
    EPS (Diluted)
    		 -1.14 -1.19 -2.64 -0.28 -1.06 -0.71 1.39 -1.44 -0.61 -0.65
    EBITDA
    		 -15.18M -16.79M -31.16M 3.09M -13.96M -9.68M 21.55M -39.65M -8.03M -8.62M
    EBIT
    		 -15.39M -17M -31.78M 3.35M -14.11M -9.83M 21.11M -39.49M -8.18M -8.75M
    Depreciation & Amortization
    		 212K 212K 622K -259K 148K 151K 434K -157K 155K 128K

    Add to Watchlist